Thermal loads inside buildings with phase change materials: Experimental results

AbstractNowadays, European policies are promoting low energy buildings because of the high amount of energy consumption of the building sector. Phase change materials (PCM) have been studied in building implementation as a passive system to reduce the energy demand. Based in the experience obtained in the experimental set-up of Puigverd de Lleida (Spain), this paper pretends to analyze experimentally the PCM performance in a scenario with internal thermal gains. The experiments were done in three different cubicles with the same internal dimensions. The selection of the constructive systems used in these three cubicles allows the authors to evaluate the impact of using PCM in a typical Mediterranean building. A domestic heat pump for summer and an electric radiator for winter were installed to control the internal temperature of the cubicles. The results of summer period experiments show that the PCM cubicle stored the heat produced by the internal loads limiting the heat dissipation to the outer environment. Therefore, the energy consumed by the HVAC system of the PCM cubicle during the cooling period is higher than that of the other cubicles that dissipated the thermal loads according to the thermal resistance of their envelopes. Therefore, the PCM selection should take into account not only the comfort temperature but also the activity and functionality of the building

Modulated model predictive control with optimized overmodulation

Finite Set Model Predictive Control (FS-MPC) has many advantages, such as a fast dynamic response and an intuitive implementation. For these reasons, it has been thoroughly researched during the last decade. However, the wave form produced by FS-MPC has a switching component whose spread spectrum remains a major disadvantage of the strategy. This paper discusses a modulated model predictive control that guarantees a spectrum switching frequency in the linear modulation range and extends its optimized response to the overmodulation region. Due to the equivalent high gain of the predictive control, and to the limit on the voltage actuation of the power converter, it is expected that the actuation voltage will enter the overmodulation region during large reference changes or in response to load impacts. An optimized overmodulation strategy that converges towards FS-MPC’s response for large tracking errors is proposed for this situation. This technique seamlessly combines PWM’s good steadystate switching performance with FS-MPC’s high dynamic response during large transients. The constant switching frequency is achieved by incorporating modulation of the predicted current vectors in the model predictive control of the currents in a similar fashion as conventional Space-Vector Pulse Width Modulation (SV-PWM) is used to synthesize an arbitrary voltage reference. Experimental results showing the proposed strategy’s good steady-state switching performance, its FS-MPC-like transient response and the seamless transition between modes of operation are presented for a permanent magnet synchronous machine drive

Predictive current control with instantaneous reactive power minimization for a four-leg indirect matrix converter

This paper presents the experimental valida¬tion of a predictive current control strategy with minimiza¬tion of the instantaneous reactive input power for a Four-Leg Indirect Matrix Converter (4Leg-IMC). The topology includes an input matrix converter stage, which provides the dc voltage for a four-leg voltage source converter (VSC) output stage. The VSC’s fourth leg provides a path for the zero sequence load current. The control technique is based on a finite control set model predictive control (FCS-MPC) strategy, whereby the switching states for the input and out¬put converters are selected by evaluating a predictive cost function. This results in a simpler approach than that seen in other well-known modulation methods, such as three-dimensional space vector modulation (3D-SVM). Positive dc voltage, (a requirement for the safe operation of the IMC) and minimization of the instantaneous input reactive power are obtained, while maintaining good tracking of the load reference currents. Furthermore, soft switching is achieved by synchronizing the state changes in the input stage with the application of zero voltage space vectors in the inverter stage. The control strategy is experimentally verified using a laboratory prototype

A targeted likelihood estimation comparing cefepime and piperacillin/tazobactam in critically ill patients with community-acquired pneumonia (CAP)

Cefepime and piperacillin/tazobactam are antimicrobials recommended by IDSA/ATS guidelines for the empirical management of patients admitted to the intensive care unit (ICU) with community-acquired pneumonia (CAP). Concerns have been raised about which should be used in clinical practice. This study aims to compare the effect of cefepime and piperacillin/tazobactam in critically ill CAP patients through a targeted maximum likelihood estimation (TMLE). A total of 2026 ICU-admitted patients with CAP were included. Among them, (47%) presented respiratory failure, and (27%) developed septic shock. A total of (68%) received cefepime and (32%) piperacillin/tazobactam-based treatment. After running the TMLE, we found that cefepime and piperacillin/tazobactam-based treatments have comparable 28-day, hospital, and ICU mortality. Additionally, age, PTT, serum potassium and temperature were associated with preferring cefepime over piperacillin/tazobactam (OR 1.14 95% CI [1.01–1.27], p = 0.03), (OR 1.14 95% CI [1.03–1.26], p = 0.009), (OR 1.1 95% CI [1.01–1.22], p = 0.039) and (OR 1.13 95% CI [1.03–1.24], p = 0.014)]. Our study found a similar mortality rate among ICU-admitted CAP patients treated with cefepime and piperacillin/tazobactam. Clinicians may consider factors such as availability and safety profiles when making treatment decisions

Análisis Estructural de Tanque Cisterna Semirremolque Fabricado en Aleación de Aluminio para Transporte de Combustibles Líquidos

En este trabajo se estudia el comportamiento estructural de un tanque cisterna semirremolque de aleación de aluminio, fabricado por la firma Tanques Fangio S.A. de la ciudad de Pergamino, provincia de Buenos Aires. Mediante modelización y análisis a través del método de elementos finitos (FEM), se estudia el diseño ‘A’ (modelo clásico), para compararlo luego con un diseño ‘B’ (modelo americano). En ambos casos se estiman los esfuerzos estáticos internos a los cuales se encuentran sometidos los distintos componentes de la estructura del tanque semirremolque, respetando las cargas impuestas por las especificaciones DOT. La modelización, discretización tridimensional y cálculo FEM permiten abordar a los valores de tensiones y deformaciones presentes en ambos modelos. Se concluye que el modelo ‘B’ presenta mejor comportamiento estructural lográndose una mejor relación costo-beneficio

Nanoinformatics: developing new computing applications for nanomedicine

Nanoinformatics has recently emerged to address the need of computing applications at the nano level. In this regard, the authors have participated in various initiatives to identify its concepts, foundations and challenges. While nanomaterials open up the possibility for developing new devices in many industrial and scientific areas, they also offer breakthrough perspectives for the prevention, diagnosis and treatment of diseases. In this paper, we analyze the different aspects of nanoinformatics and suggest five research topics to help catalyze new research and development in the area, particularly focused on nanomedicine. We also encompass the use of informatics to further the biological and clinical applications of basic research in nanoscience and nanotechnology, and the related concept of an extended ?nanotype? to coalesce information related to nanoparticles. We suggest how nanoinformatics could accelerate developments in nanomedicine, similarly to what happened with the Human Genome and other -omics projects, on issues like exchanging modeling and simulation methods and tools, linking toxicity information to clinical and personal databases or developing new approaches for scientific ontologies, among many others

A Single-Run Next-Generation Sequencing (NGS) Assay for the Simultaneous Detection of Both Gene Mutations and Large Chromosomal Abnormalities in Patients with Myelodysplastic Syndromes (MDS) and Related Myeloid Neoplasms

Chromosomal abnormalities and somatic mutations are found in patients with myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in around 50-80% of cases. The identification of these alterations is important for the accurate diagnosis and prognostic classification of these patients. Often, an apparently normal or failed karyotype might lead to an inadequate estimation of the prognostic risk, and several strategies should be combined to solve these cases. The aim of this study was to introduce a novel next-generation sequencing (NGS)-based strategy for the simultaneous detection of all the clinically relevant genetic alterations associated with these disorders. We validated this approach on a large cohort of patients by comparing our findings with those obtained with standard-of-care methods (i.e., karyotype and SNP-arrays). We show that our platform represents a significant improvement on current strategies in defining diagnosis and risk stratification of patients with MDS and myeloid-related disorders. Myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms are clonal disorders that share most of their cytogenetic and molecular alterations. Despite the increased knowledge of the prognostic importance of genetics in these malignancies, next-generation sequencing (NGS) has not been incorporated into clinical practice in a validated manner, and the conventional karyotype remains mandatory in the evaluation of suspected cases. However, non-informative cytogenetics might lead to an inadequate estimation of the prognostic risk. Here, we present a novel targeted NGS-based assay for the simultaneous detection of all the clinically relevant genetic alterations associated with these disorders. We validated this platform in a large cohort of patients by performing a one-to-one comparison with the lesions from karyotype and single-nucleotide polymorphism (SNP) arrays. Our strategy demonstrated an approximately 97% concordance with standard clinical assays, showing sensitivity at least equivalent to that of SNP arrays and higher than that of conventional cytogenetics. In addition, this NGS assay was able to identify both copy-neutral loss of heterozygosity events distributed genome-wide and copy number alterations, as well as somatic mutations within significant driver genes. In summary, we show a novel NGS platform that represents a significant improvement to current strategies in defining diagnosis and risk stratification of patients with MDS and myeloid-related disorder

Multicentre, randomised, open-label, phase IV-III study to evaluate the efficacy of cloxacillin plus fosfomycin versus cloxacillin alone in adult patients with methicillin-susceptible Staphylococcus aureus bacteraemia: Study protocol for the SAFO trial

Introduction Methicillin-susceptible Staphylococcus aureus (MSSA) bacteraemia is a frequent condition, with high mortality rates. There is a growing interest in identifying new therapeutic regimens able to reduce therapeutic failure and mortality observed with the standard of care of beta-lactam monotherapy. In vitro and small-scale studies have found synergy between cloxacillin and fosfomycin against S. aureus. Our aim is to test the hypothesis that cloxacillin plus fosfomycin achieves higher treatment success than cloxacillin alone in patients with MSSA bacteraemia. Methods We will perform a superiority, randomised, open-label, phase IV-III, two-armed parallel group (1:1) clinical trial at 20 Spanish tertiary hospitals. Adults (=18 years) with isolation of MSSA from at least one blood culture =72 hours before inclusion with evidence of infection, will be randomly allocated to receive either cloxacillin 2 g/4-hour intravenous plus fosfomycin 3 g/6-hour intravenous or cloxacillin 2 g/4-hour intravenous alone for 7 days. After the first week, sequential treatment and total duration of antibiotic therapy will be determined according to clinical criteria by the attending physician. Primary endpoints: (1) Treatment success at day 7, a composite endpoint comprising all the following criteria: patient alive, stable or with improved quick-Sequential Organ Failure Assessment score, afebrile and with negative blood cultures for MSSA at day 7. (2) Treatment success at test of cure (TOC) visit: patient alive and no isolation of MSSA in blood culture or at another sterile site from day 8 until TOC (12 weeks after randomisation). We assume a rate of treatment success of 74% in the cloxacillin group. Accepting alpha risk of 0.05 and beta risk of 0.2 in a two-sided test, 183 subjects will be required in each of the control and experimental groups to obtain statistically significant difference of 12% (considered clinically significant). Ethics and dissemination Ethical approval has been obtained from the Ethics Committee of Bellvitge University Hospital (AC069/18) and from the Spanish Medicines and Healthcare Product Regulatory Agency (AEMPS, AC069/18), and is valid for all participating centres under existing Spanish legislation. The results will be presented at international meetings and will be made available to patients and funders. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ

A chemical survey of exoplanets with ARIEL

Thousands of exoplanets have now been discovered with a huge range of masses, sizes and orbits: from rocky Earth-like planets to large gas giants grazing the surface of their host star. However, the essential nature of these exoplanets remains largely mysterious: there is no known, discernible pattern linking the presence, size, or orbital parameters of a planet to the nature of its parent star. We have little idea whether the chemistry of a planet is linked to its formation environment, or whether the type of host star drives the physics and chemistry of the planet’s birth, and evolution. ARIEL was conceived to observe a large number (~1000) of transiting planets for statistical understanding, including gas giants, Neptunes, super-Earths and Earth-size planets around a range of host star types using transit spectroscopy in the 1.25–7.8 μm spectral range and multiple narrow-band photometry in the optical. ARIEL will focus on warm and hot planets to take advantage of their well-mixed atmospheres which should show minimal condensation and sequestration of high-Z materials compared to their colder Solar System siblings. Said warm and hot atmospheres are expected to be more representative of the planetary bulk composition. Observations of these warm/hot exoplanets, and in particular of their elemental composition (especially C, O, N, S, Si), will allow the understanding of the early stages of planetary and atmospheric formation during the nebular phase and the following few million years. ARIEL will thus provide a representative picture of the chemical nature of the exoplanets and relate this directly to the type and chemical environment of the host star. ARIEL is designed as a dedicated survey mission for combined-light spectroscopy, capable of observing a large and well-defined planet sample within its 4-year mission lifetime. Transit, eclipse and phase-curve spectroscopy methods, whereby the signal from the star and planet are differentiated using knowledge of the planetary ephemerides, allow us to measure atmospheric signals from the planet at levels of 10–100 part per million (ppm) relative to the star and, given the bright nature of targets, also allows more sophisticated techniques, such as eclipse mapping, to give a deeper insight into the nature of the atmosphere. These types of observations require a stable payload and satellite platform with broad, instantaneous wavelength coverage to detect many molecular species, probe the thermal structure, identify clouds and monitor the stellar activity. The wavelength range proposed covers all the expected major atmospheric gases from e.g. H2O, CO2, CH4 NH3, HCN, H2S through to the more exotic metallic compounds, such as TiO, VO, and condensed species. Simulations of ARIEL performance in conducting exoplanet surveys have been performed – using conservative estimates of mission performance and a full model of all significant noise sources in the measurement – using a list of potential ARIEL targets that incorporates the latest available exoplanet statistics. The conclusion at the end of the Phase A study, is that ARIEL – in line with the stated mission objectives – will be able to observe about 1000 exoplanets depending on the details of the adopted survey strategy, thus confirming the feasibility of the main science objectives.Peer reviewedFinal Published versio